一般外科

Medicine & Life Sciences

1. Meta-Analysis 100%
2. Randomized Controlled Trials 66%
3. Breast Neoplasms 53%
4. Neoplasms 44%
5. Systematic Reviews 43%
6. Hepatocellular Carcinoma 39%
7. glucose-regulated proteins 37%
8. Neoplasm Metastasis 31%
9. Colorectal Neoplasms 30%
10. Confidence Intervals 28%
11. Taiwan 28%
12. Rectal Neoplasms 28%
13. Nicotinic Receptors 27%
14. Colonic Neoplasms 25%
15. Cell Movement 23%
16. Nicotine 21%
17. Therapeutics 21%
18. pterostilbene 20%
19. MicroRNAs 16%
20. Robotics 15%
21. Curcumin 15%
22. Apoptosis 15%
23. Down-Regulation 15%
24. Breast 14%
25. Neoplastic Stem Cells 14%
26. Laparoscopy 14%
27. Incidence 14%
28. Carcinogenesis 14%
29. Epithelial-Mesenchymal Transition 14%
30. Bariatric Surgery 13%
31. Stomach Neoplasms 13%
32. Liver 13%
33. Odds Ratio 13%
34. PubMed 13%
35. Gastric Bypass 13%
36. Lung Neoplasms 12%
37. Population 12%
38. Pain 12%
39. Safety 12%
40. Survival 12%
41. Stomach 12%
42. Antrodia 11%
43. Triple Negative Breast Neoplasms 11%
44. Thrombomodulin 11%
45. Libraries 11%
46. Gastrectomy 11%
47. Autophagy 10%
48. Morbid Obesity 10%
49. Weight Loss 10%
50. Databases 10%
51. Colon 10%
52. Advanced Glycation End Products 10%
53. Quality of Life 10%
54. Length of Stay 10%
55. Smoking 9%
56. Macrophages 9%
57. Lung 9%
58. Growth 9%
59. Fluorouracil 9%
60. Up-Regulation 9%
61. gemcitabine 9%
62. Carcinoma 9%
63. Gene Expression 9%
64. Appendectomy 9%
65. Recurrence 8%
66. Survivin 8%
67. Drug Therapy 8%
68. Serum 8%
69. Intussusception 8%
70. Proteins 8%
71. Sorafenib 8%
72. Cohort Studies 8%
73. Appendicitis 8%
74. Mortality 8%
75. In Vitro Techniques 8%
76. Catenins 8%
77. SERPIN-B5 8%
78. Small Interfering RNA 8%
79. Prostatic Neoplasms 8%
80. antrocin 8%
81. Genes 7%
82. Resveratrol 7%
83. Learning Curve 7%
84. Shared Decision Making 7%
85. Phloretin 7%
86. p38 Mitogen-Activated Protein Kinases 7%
87. Thyroid Neoplasms 7%
88. Herniorrhaphy 7%
89. Hemorrhoidectomy 7%
90. Hormones 7%
91. Body Mass Index 7%
92. destruxin B 7%
93. Heterografts 7%
94. Propofol 7%
95. ErbB Receptors 7%
96. Cell Death 7%
97. Wounds and Injuries 7%
98. Inguinal Hernia 7%
99. Lymph Nodes 7%
100. Gallbladder Diseases 6%